The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer

Cancer

Volumn 71, Issue 8, 1993, Pages 2454-2460

  Mayer, Astrid ^a   Takimoto, Masafumi ^b   Fritz, Elke ^a   Schellander, Georgine ^a   Kofler, Klaus ^a   Ludwig, Heinz ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

colorectal cancer; EGFR; immunohistochemistry; PCNA; P glycoprotein; survival in colorectal cancer

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; GLYCOPROTEIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL DIVISION; COLORECTAL CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; DRUG RESISTANCE; FEMALE; HUMAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0027415146     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2     Document Type: Article

References (32)

1. Cancer statistics and trends
2. A multivariate analysis of pathologic prognostic indicators in large bowel cancer
3. The classification of cancer of the rectum
4. Carcinoma: grading and practical application
5. The relationship of depth of penetration and tumor size to the number of positive nodes in Dukes C colorectal cancer
6. Vascular and neural invasion in colorectal carcinoma: incidence and prognostic significance
7. Variables correlated with the risk of lymph node metastasis in early rectal cancer
8. Flow cytometric DNA index in the prognosis of colorectal cancer
9. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma
10. Allelotype of colorectal carcinomas
11. Autoantibody to a nuclear antigen in proliferating cells
12. Cyclin/PCNA is the auxiliary protein of DNA polymerase delta
13. Cell cycle‐dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase
14. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer
15. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer
16. The epidermal growth factor receptor in human pancreatic cancer
17. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas
18. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors
19. Expression of a multidrug‐resistance gene in human tumors and tissues
20. P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins
21. P‐Glycoprotein is targeted to adhesion plaques, retraction fibers and microspikes in drug resistant KB‐VI epidermoid carcinoma cells [abstract]
22. MDR1 gene expression and treatment outcome in acute myeloid leukemia
23. Relationship of the expression of the multidrug resistance gene product (P‐glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis
24. The prognostic value of PCNA (proliferating cell nuclear antigen) immunostaining in gastrointestinal lymphomas
25. Immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen may be a good indicator of prognosis in hemangiopericytomas
26. Application of proliferating nuclear antigen (PCNA) immunostaining in gastric carcinoma
27. Ten year results from the national surgical adjuvant breast and bowel project (NSABP) clinical trial evaluating the use of L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer
28. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki‐67
29. Ki‐67 derived proliferative activity in colorectal adenocartinoma with prognostic correlations
30. Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma and carcinoma
31. Epidermal growth factor expression in colorectal cancer
32. Expression of a multidrug resistance gene in human cancer